ARCHIVES

FDA’s Handling Of UFT Raises Questions About Agency’s Isolation, Grasp Of Science.

This article is from The Cancer Letter archive.

Vol. 26 No. 29 | July 21, 2000

Download PDF Visit The Full Archive

Related Articles

Medicare: Clinton Budget Revives Proposal To End Physician Drug Markup

February 6, 1998

What? Only a “B”? NLST Co-Principal Investigator Begs to Differ with USPSTF Lung Cancer Screening Grade

August 9, 2013

NMP22 Assay More Effective Than Conventional Lab Test

January 27, 2006

Advisors Voted For Provenge Approval Despite Fundamental Flaws In Trials.

April 13, 2007

Interactive RPGs Deadline Is Feb. 20

December 13, 1991

DeVita Seeks End to Funding For CROS, Reacts With Anger To Charge Of “Central Direction From Washington”

February 20, 1981